Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 94,29
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New.
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
EUR 96,66
Quantité disponible : 1 disponible(s)
Ajouter au panierPAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
EUR 92,65
Quantité disponible : 1 disponible(s)
Ajouter au panierPAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 104,63
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 92,64
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 101,62
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 115,79
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
EUR 118,16
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 107,55
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Langue: anglais
Edité par Springer Nature Switzerland AG, CH, 2019
ISBN 10 : 3030064476 ISBN 13 : 9783030064471
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-Uni
EUR 125,68
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : New. Softcover Reprint of the Original 1st 2018 ed.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 123,42
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 115,34
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
EUR 82,91
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : NEW.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 115,33
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
EUR 117,87
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Brand New. reprint edition. 9.25x6.10 inches. In Stock.
EUR 135,42
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 231.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 128,49
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 144,61
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New.
Langue: anglais
Edité par Springer International Publishing, 2019
ISBN 10 : 3030064476 ISBN 13 : 9783030064471
Vendeur : moluna, Greven, Allemagne
EUR 106,22
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. Details several different aspects of the cochlear inflammatory processDiscusses recent clinical trials focusing on the use of anti-inflammatory agents for the treatment of drug, noise-induced and auto-immune mediated hearing loss.
EUR 153,86
Quantité disponible : 2 disponible(s)
Ajouter au panierHardcover. Etat : Brand New. 244 pages. 9.25x6.10x0.67 inches. In Stock.
EUR 95,15
Quantité disponible : 5 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Inflammatory Mechanisms in Mediating Hearing Loss | Vickram Ramkumar (u. a.) | Taschenbuch | x | Englisch | 2019 | Springer | EAN 9783030064471 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Vendeur : UK BOOKS STORE, London, LONDO, Royaume-Uni
EUR 169,96
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Langue: anglais
Edité par Springer International Publishing, Springer International Publishing, 2018
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 106,99
Quantité disponible : 1 disponible(s)
Ajouter au panierBuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Common forms of preventable hearing loss are drug and noise-induced hearing loss which are believed to be produced by a similar mechanism. The generation of reactive oxygen species appears to be a common mechanism mediating hearing loss produced by these different sources. As such, a number of laboratories have focused their research towards identifying the sources of ROS production in the cochlea following administration of chemotherapeutic agents or noise exposure. This led to the identification of ROS generating enzymes, such as xanthine oxidases, nitric oxide synthase, and NADPH oxidases which are activated and/or induced during the development of hearing loss. A consequence of these findings was the implementation of antioxidants in preclinical studies for the treatment of hearing loss. These antioxidants have provided different levels of protection in animal and human studies, but none of these have been approved by the US Food and Drug Administration for the treatmentof hearing loss. More recently, it was shown that noise-induced hearing loss was associated with recruitment of inflammatory cells and mediators in the cochlea. This finding would suggest that noise could produce injury to the cochlea which stimulates local and/or circulating inflammatory cells. A similar finding was observed in the cochlea following administration of the anticancer drug, cisplatin. In addition, our laboratory and others have provided a plausible mechanism by which noise or chemotherapeutic agents could stimulate the inflammatory response. Surprisingly, this mechanism involves ROS activation of transcription factors linked to inflammatory processes in the cochlea. These studies have led to the use of anti-inflammatory agents for the treatment of hearing loss. Preliminary studies targeting inflammatory cytokines appear especially promising in preclinical studies. A primary goal of this project is to describe our current understanding of theoxidant hypothesis of noise and drug-induced hearing loss and show how this relates to cochlear inflammation. Several different aspects of the cochlear inflammatory process will be discussed in detail, ranging from the sources of inflammatory cells, chemokines, inflammatory cytokines, and cochlea resident immune cells. Molecular pathways leading to activation of the local inflammatory process will be highlighted and treatment options will be discussed. The relevance of certain clinically used anti-inflammatory interventions, such as trans-typmanic steroids will also be discussed. Furthermore, we will examine recent patents focusing on the use of anti-inflammatory agents for the treatment of drug and noise-induced hearing loss.
Langue: anglais
Edité par Springer International Publishing, Springer International Publishing, 2019
ISBN 10 : 3030064476 ISBN 13 : 9783030064471
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 106,99
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Common forms of preventable hearing loss are drug and noise-induced hearing loss which are believed to be produced by a similar mechanism. The generation of reactive oxygen species appears to be a common mechanism mediating hearing loss produced by these different sources. As such, a number of laboratories have focused their research towards identifying the sources of ROS production in the cochlea following administration of chemotherapeutic agents or noise exposure. This led to the identification of ROS generating enzymes, such as xanthine oxidases, nitric oxide synthase, and NADPH oxidases which are activated and/or induced during the development of hearing loss. A consequence of these findings was the implementation of antioxidants in preclinical studies for the treatment of hearing loss. These antioxidants have provided different levels of protection in animal and human studies, but none of these have been approved by the US Food and Drug Administration for the treatmentof hearing loss. More recently, it was shown that noise-induced hearing loss was associated with recruitment of inflammatory cells and mediators in the cochlea. This finding would suggest that noise could produce injury to the cochlea which stimulates local and/or circulating inflammatory cells. A similar finding was observed in the cochlea following administration of the anticancer drug, cisplatin. In addition, our laboratory and others have provided a plausible mechanism by which noise or chemotherapeutic agents could stimulate the inflammatory response. Surprisingly, this mechanism involves ROS activation of transcription factors linked to inflammatory processes in the cochlea. These studies have led to the use of anti-inflammatory agents for the treatment of hearing loss. Preliminary studies targeting inflammatory cytokines appear especially promising in preclinical studies. A primary goal of this project is to describe our current understanding of theoxidant hypothesis of noise and drug-induced hearing loss and show how this relates to cochlear inflammation. Several different aspects of the cochlear inflammatory process will be discussed in detail, ranging from the sources of inflammatory cells, chemokines, inflammatory cytokines, and cochlea resident immune cells. Molecular pathways leading to activation of the local inflammatory process will be highlighted and treatment options will be discussed. The relevance of certain clinically used anti-inflammatory interventions, such as trans-typmanic steroids will also be discussed. Furthermore, we will examine recent patents focusing on the use of anti-inflammatory agents for the treatment of drug and noise-induced hearing loss.
Vendeur : Basi6 International, Irving, TX, Etats-Unis
EUR 193,69
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Langue: anglais
Edité par Springer Nature Switzerland AG, CH, 2019
ISBN 10 : 3030064476 ISBN 13 : 9783030064471
Vendeur : Rarewaves.com UK, London, Royaume-Uni
EUR 118,54
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : New. Softcover Reprint of the Original 1st 2018 ed.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 184,53
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Vendeur : Romtrade Corp., STERLING HEIGHTS, MI, Etats-Unis
EUR 223,06
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 270,97
Quantité disponible : 2 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 287,96
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Used. pp. 450.